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Many eukaryotic genes are organized into nmitigene 
loci in which genes with related function are coordi- 
nmely expressed or differentially regulated during 
development. There are two key questions about the 
regulation of such loci. First, how is a large locus that 
may extend over hundreds of kilobases of DNA con- 
verted to a transcriptionally active state? Second, how 
are genes in such an activated region differentially 
regulated so that some are active and others silent at 
a particular developmental stage, and so that they 
can switch their expression state as development 
progresses? 
Transcriptional control elements 
In addressing the question of how loci are acti- 
vated, we must consider the various elements that 
have been characterized on the basis of their ability to 
modulate the transcription of eukaryotic genes. It 
should be borne in mind that the terms used to 
describe these elements are functional definitions that 
entirely depend on the parameters of the assay used 
for the definition. 
The best-characterized of the elements known to 
be important for gene regulation is the promoter: the 
region immediately upstream of each transcription 
initiation site. The promoter consists of binding sites 
for upstream factors and the basic transcription 
machinery, which is a very large complex with the 
TATA binding factor (TBP) as the central component. 
There are also other transcription factors, which act to 
promote or inhibit the basic machineryl2. It has been 
shown that these elements are involved at many levels 
of control, such as tissue spec '~' ;t'.,', developmental 
and temporal specificity, and in regulating the level of 
gene expression. The presence of factors bound to an 
active promoter can ust, ally be detected in chromatin 
as a region that is hypersensitive to DNase I digestkm. 
It is important to note, however, that a promoter alone 
cannot generally drive efficient expression of a gene in 
cell transfection experiments and often fails to give 
any expression i  transgenic mice. 
A second type of element that can potentiate gene 
transcription is the enhancer. The first enhancers to be 
characterized were of viral origin, and were originally 
defined in transient transfection assays as fragments of 
DNA that would stimulate transcription of a gene in 
cis on the same plasmid3.~. The same functional assay 
was used to define cellular elements with similar prop- 
erties, and it was found that these enhancers can show 
cell-type specificity that reflects the in vivo expression 
of their associated genes5. An enhancer typically 
contains a collection of sites that can bind activating 
or suppressing protein factors. Enhancers that function 
in transient assays can be created with relative ease 
by multimerization f individual protein-binding site#', 
suggesting that the functional definition may en- 
compass a wide range of different elements. The term 
enhancer has since become used for almost any piece 
of DNA that stimulates transcription in almost any 
assay. However, it has also become clear that the pres- 
ence of one or more enhancers i not sufficient to acti- 
vate transcription i  all test systems. In particular, in 
studies with transgenic mice almost all genes are not 
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expressed properly despite the presence of enhancers. 
Expression levels are generally low or undetectable, 
and are not related to the copy-number of the trans- 
gene construct. The normal pattern of temporal and 
tissue-specific expression of the gene is also disturbed. 
Founder mice that have integrated the transgenic con- 
struct at a different chromosomal position often show 
different patterns of expression. This phenomenon, 
where the presence of other regulatory regions in the 
host genome at or near the site of integration of the 
construct influences the level and specificity of ex- 
pression of the transgene, is called a position effect. 
These observations led to the formulation of a new 
functional definition, that of the locus control region 
(LCR). The LCR was originally identified as a control 
region upstream from the human [~-globin locus 
(Fig. 1) and several other such elements have now 
been described that are important for the activation of 
various loci, including CD2 (Ref. 8), lymzyme 9 and the 
MHC (S. Carson and M. Wiles, pers. commun.). LCRs 
are characterized by tissue-specific, developmentally 
stable DNase-I-hypersensitive sites. Such sites are 
thought to be short stretches of DNA that are not 
complexed into nucleosomes. 
An LCR has been functionally defined as an ele- 
ment that confers expression upon a transgene, to a 
level that is independent of its site of integration i  the 
host genome but dependent on its copy numberL 
Thus LCR activity is quite differently defined from 
enhancer activity, using very different functional 
assays. In particular, the fact that the DNA is not inte- 
grated into chromatin in a transient assay allows the 
detection of a wide variety of sequences that have 
enhancer activity, but not LCR activity. The converse 
can also be the case, for example, in the [~-globin 
locus the LCR hypersensitive sites HS3 and 4 (Fig. 1) 
do not act as enhancers in transient transfectionsm~, 
although they are powerful LCR elementsla-14. HS2 
shows activity in both types of a~aynaS. 16, suggesting 
that there can be overlap between these two func- 
tional definitions. Given this overlap, it is not surpris- 
ing that LCRs also contain multiple factor-binding sites, 
several of which have been shown to be important for 
activity of the element. However, in contrast o the 
ease with which enhancer activity can be obtained by 
binding site multimerization, we have as yet been 
unable to reproduce LCR activity using this approach. 
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This suggests that the precise 
arrangement of factor-binding 
sites may be critical for LCR 
functionlT. 18. 
LCR function could conceiv- 
ably be achieved by insulating 
the transgene from position 
effects. An insulating function 
of this type has been described 
for the Drosopbila specialized 
chromatin structure (scs and 
scs') elements 19, sequences that 
were originally identified as 
DNase-I-hypersensitive sites. 
However, the possibility that 
the LCRs work by an insulating 
mechanism has been effectively 
excluded through an analysis 
of mice carrying a single copy 
of an LCR linked to a globin 
gene. These mice showed high 
levels of tissue-specific ex- 
pression of the transgene s.2°, 
but low-level expression of the 
gene was detected in other 
tissues (D. Meijer, pers. com- 
mun.), indicating that it was 
not protected from positive 
position effects. Instead, exten- 
sive functional analysis has 
shown that the LCR is a domi- 
nant positive activator that may 
act by forming very stable com- 
plexes with genes, to the ex- 
clusion of other regulatory 
elementsta,16,1s. 
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Top: Structure ofthe human 13-globin locus. Vertical arrows indicate DNase I hypersensitive 
sites. DNase-l-sensitivity is shown graphically below the locus, The exact point of transition 
from sensitive to insensitive chromatin (dashed line) has not yet been determined. 
Bottom: Production of human globin chains during development. 
One property of the [3-globin LCR is an ability to 
induce sensitivity to DNase I digestion over an exten- 
sive region of chromatin 21, suggesting that the locus 
may be present as a single large 'open' domain in 
erythroid cells. Although in the transgenic experiments 
the hypersensitive sites (HS) are restored 7, it is not 
known at present whether an equally large region of 
chromatin is affected, nor is it known whether the 
generation of HS is autonomous or requires the pres- 
ence of other elements, uch as a promoter. 
In addition to promoters, enhancers and LCRs, 
other regulatory elements have been described. The 
Drosophila specialized, chromatin structure elements 
mentioned above insulate regulatory elements from 
each other thereby preventing position effects, but 
they do not activate transcription or are they matrix 
attachment sites 19,zz. In addition to the scs boundary 
elements, at least one boundary element has been 
identified in the Drosophila Bithorax complex thai is 
essential for the correct temporal expression of the 
flanking genes z3. No such elements have yet been 
functionally mapped in vertebrate loci, although they 
are widely assumed to be present. Sites that are 
thought to be nuclear matrix attachment regions z4 
(MAR) or chromosomal scaffold attachment regions -'5 
(SAR) have not yet been shown to function as bound- 
ary elements in a transgenic experiment. This is also 
the case for the attachment sites (A elements) that are 
found at the boundaries of the DNase-I-sensitive 
chicken lysozyme gene dolnain 2¢'. These elements 
were part of a chicken Jysozyme gene domain con- 
struct that had copy-number dependent expression 
when introduced into transgenic mice 27, but have not 
yet been shown to act as boundary elements when 
tested separately from the rest of the domain. The role 
of attachment sites is therefore as yet unclear. They 
may play a role in organizing chromosomal DNA for 
passage through the cell cycle. They might also have a 
part in nonspecific repression mediated by higher 
order chromatin structures. General functions uch as 
these are likely to be antagonistic to the achievement 
of specific programmes of gene activation during 
development, and the role of an LCR may well be to 
override such effects and convert a locus to a stable 
transcriptionally active site. 
Gene regulation in multigene loci 
Detailed analysis of the mechanisms of regulation 
in multigene loci is now becoming possible with the 
development of methods for generating transgenic 
mice carrying large DNA fragments. The human [3- 
globin cluster has been particularly useful for these 
types of studies, as all of the sequences required for 
full expression of the locus in chromatin have been 
defined, and the LCR is located on one piece of DNA. 
The globin genes are arranged in the order in which 
they are expressed uring development (Fig. 1) with 
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Scheme for differentiating between tracking and frequency models by examining the 
effect of varying the relative distance of two I~-globin genes from the LCR. Loop 
formation is indicated by curved arrows. A straight solid arrow indicates a tracking 
effect. A straight dashed arrow indicates tracking blocked or attenuated bythe 
presence of an active gene. 
¢-globin showing an embryonic and early foetal profile 
and 'y-globin being expressed in the late embryonic 
stage and throughout the foetal period as. Expression of 
13-globin increases during the foetal period and this 
becomes the predominant species in the adult 
(reviewed in Ref. 29). The LCR is required for acti- 
vation of all of the genes, since in naturally occurring 
mutants in which the LCR is deleted, the genes are 
intact, but silent30..*v. 
Extensive studies in transgenic mice have indicated 
that a major part of the developmental specificity of 
the IB-globin genes resides in the protnoters a°,32,33. For 
example, it is clear that the promoters of the ~/-globin 
genes bind one or more repressing factors which 
silence transcription i  the adult, and that this process 
can be reversed by mutations in the binding sites for 
these factors34,35. A substantial contribution is also 
made by differential activity of individual hypersen- 
sitive LCR sites during development36. A further level 
of regulation appears to result from competition 
among genes for activation by the LCR. This type of 
intergenic ompetition was originally documented in 
transient expression assays with the SV40 enhance#7.38 
and, more recently, with the chicken 13-globin 
enhance# 9. The latter study showed that active tran- 
scription is required for this process. 
Genetic evidence for competition in the [3-globin 
locus in vivo comes from the observation that in 
individuals with hereditary persistence of foetal 
haemoglobin, increased adult expression of a ~/-globin 
gene caused by mutations in the gene promoter 
(reviewed in Ref. 40) results in a corresponding down- 
regulation of the 13-globin gene 
from the same allele "~I. Mutations 
and small deletions that inactivate 
the 13-globin gene promoter cause 
only a slight increase in3' ex- 
pression in the adulO °, suggesting 
that competition in the locus is 
polar. This model first arose from 
transgenic mouse studies 4a which 
showed that while a gene proxi- 
mal to the LCR could compete the 
expression of a distal gene, one 
located distally was unable to 
compete effectively. Polar compe- 
tition is interesting mechanistically 
and provides us with a potential 
means to investigate how the LCR 
acts over long distances. A variety 
of mechanisms have been pro- 
posed to explain the action of 
genetic ontrol elements over long 
distances. These include polym- 
erase tracking, the spreading of 
chromatin structures, and direct 
contact between separated ele- 
ments through loop formation. 
Although in recent years the loop 
hypothesis has been supported by 
transient expression ~3 and in vitro 
studies% it should be remembered 
that, so far, the only direct evi- 
dence for contact between two 
separated control elements as a mechanism for tran- 
scriptional activation in chromatin is the phenomenon 
of transvection i Drosophila ~5. 
Polar competition could be explained by either 
tracking or spreading models. In these models, pro- 
teins (e.g. polymerases) or protein complexes move 
along the DNA in a linear fashion, altering the 
chromatin structure in the process. The blocking or 
attenuation of such complexes by the first gene 
encountered would result in a polar effect. Alterna- 
tively, polarity might be explained by a frequency 
model, in which movement of DNA in solution leads 
to random contact between promoter and LCR and 
the formation of stable loops. According to this 
stochastic model, the proximal ~-globin genes would 
interact with the LCR more frequently and this would 
accentuate the effect of a stronger promoter during 
the foetal stage. The less frequent interaction of the 
distally located I~-.globin gene with the LCR would 
place it at a disadvantage even when its promoter is 
stronger in the adult stage, and would only allow it 
to be expressed fully when the 'y-globin genes are 
completely silenced by stage-specific factors. These 
models could be directly tested in mice transgenic for 
the complete ~-globin locus 46, by placing a second 
13-globin gene at different points in the locus (Fig. 2). 
A tracking model predicts that the competitive ffect 
of the proximal 13-globin gene will be similar wher- 
ever it is located. A frequency model predicts that the 
proximal 13-globin gene will compete less effectively 
as it is moved away from the LCR and towards the 
distal ~-globin gene (Fig. 2). 
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Implications for other multigene loci 
From the study of the 13-globin locus, it has 
become clear that individual regulatory elements in a 
multigene locus are not necessarily restricted to acting 
on any one gene. Instead there can be an extra level 
of complexity with elements acting over long distances 
on several genes. The result of this is a situation where 
expression of one gene can affect the timing and the 
level of expression of another gene. Regulation of 
other multigene loci probably involves a similar type 
of control. For example, the order of genes within the 
Hox clusters has been maintained from Drosophila to 
humans, suggesting that this regulatory principle may 
also operate in these loci 47. Although it has been 
shown that the intergenic flanking regions of certain 
Hox genes can confer correct temporal expression in 
transgenic mice 48,49, it is not yet known whether the 
genes are also expressed at the correct level. Both the 
timing and the level of expression of each gene are 
likely to be important for pattern formation. Since cor- 
rect temporal expression of a given gene requires 
regulatory sequences immediately flanking the next 
gene, it is probable that its level of expression will 
depend on the presence or absence of neighbouring 
genes. 
Advances in investigating the control of multigene 
loci will continue to depend on stringent functional 
analysis in vivo. The ability to introduce large DNA 
molecules into mice will be important for such stud- 
ies. Homologous recombination also offers a par- 
ticularly good opportunity to carry out this type of 
analysis, since any putative regulatory region can be 
deleted, modified or inserted in situ. It is likely that 
there will be significant progress in understanding the 
regulation of complex gene loci in the next few 
years. 
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